BBHvsIBTF
VanEck Biotech ETF against iShares iBonds Dec 2025 Term Treasury ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | IBTF | |
|---|---|---|
| Expense ratio | 0.35% | 0.070% |
| Assets | $483M | $1.4B |
| Net flow, 1 month | −$5M | — |
| Net flow, 1 year | −$21M | −$367M |
| Return, YTD | +24.9% | — |
| Return, 1 year | +35.7% | 0.0% |
| Avg daily volume | 10K | — |
| Holdings | 26 | 32 |
| Listed | Nov 23, 1999 | Feb 25, 2020 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS